Search Within

Stephen R Broderick

Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
Groups
  1. Department of Pathology and Laboratory Medicine (11)
  2. GSK Faculty (11)
  3. Human Oncology and Pathogenesis Program (11)
  4. Surgery (11)
  5. Tow Center for Developmental Oncology (TCDO) (11)
  6. Biostatistics Service (6)

More Groups

People
  1. Marc Ladanyi (11)
  2. William Pao (11)
  3. Valerie Rusch (10)
  4. Dhananjay Chitale (8)
  5. Venkatraman Seshan (6)
  6. William Gerald (6)

More People

Years
  1. 2010 (1)
  2. 2009 (1)
  3. 2008 (4)
  4. 2007 (7)
Publications
  1. Journal of Thoracic Oncology (2)
  2. Nature (2)
  3. Journal of Clinical Oncology (1)
  4. Journal of Molecular Diagnostics (1)
  5. Laboratory Investigation (1)
  6. Modern Pathology (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. Elsevier Inc. (2)
  3. American Association for Cancer Research (1)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Science Inc. (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (13)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • SCCRO promotes glioma formation and malignant progression in mice
    Journal Article

    Broderick, S. R.; Golas, B. J.; Pham, D.; Towe, C. W.; Talbot, S. G.; Kaufman, A.; Bains, S.; Huryn, L. A.; Yonekawa, Y.; Carlson, D.; more...
    NeoPlasia (2010)

    Fulltext@MSK | Save
  • An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
    Journal Article

    Chitale, D.; Gong, Y.; Taylor, B. S.; Broderick, S.; Brennan, C.; Somwar, R.; Golas, B.; Wang, L.; Motoi, N.; Szoke, J.; more...
    Oncogene (2009)

    Fulltext@MSK | Save
  • An integrated analysis of gene expression, copy number alterations, and kinase pathway mutations in lung adenocarcinoma reveals frequent loss of the MAPK phosphatase Gene DUSP4 in EGFR mutant tumors
    Meeting Abstract

    Chitale, D.; Gong, Y.; Broderick, S.; Brennan, C.; Taylor, B. S.; Somwar, R.; Wang, L.; Motoi, N.; Szoke, J.; Sander, C.; more...
    Laboratory Investigation (2008)

    Fulltext@MSK | Save
  • An integrated analysis of gene expression, copy number alterations, and kinase pathway mutations in lung adenocarcinoma reveals frequent loss of the MAPK phosphatase gene DUSP4 in EGFR mutant tumors
    Meeting Abstract

    Chitale, D.; Gong, Y.; Broderick, S.; Brennan, C.; Taylor, B. S.; Somwar, R.; Wang, L.; Motoi, N.; Szoke, J.; Sander, C.; more...
    Modern Pathology (2008)

    Fulltext@MSK | Save
  • Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
    Journal Article

    Marks, J. L.; Broderick, S.; Zhou, Q.; Chitale, D.; Li, A. R.; Zakowski, M. F.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.; Seshan, V. E.; more...
    Journal of Thoracic Oncology (2008)

    Fulltext@MSK | Save
  • Somatic mutations affect key pathways in lung adenocarcinoma
    Journal Article

    Ding, L.; Getz, G.; Wheeler, D. A.; Mardis, E. R.; McLellan, M. D.; Cibulskis, K.; Sougnez, C.; Greulich, H.; Muzny, D. M.; Morgan, M. B.; more...
    Nature (2008)

    Fulltext@MSK | Save
  • Integrated genomic analysis of lung adenocarcinomas identifies loss of the MAPK phosphatase gene DUSP4 in most EGFR mutant tumors
    Meeting Abstract

    Broderick, S. R.; Chitale, D.; Motoi, N.; Gong, Y.; Pao, W.; Venkatraman, E.; Rusch, V.; Brennan, C.; Gerald, W.; Ladanyi, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Evaluation of the sequenom MassARRAY system for detecting mutations in the EGFRand KRAS genes in 174 lung adenocarcinomas
    Meeting Abstract

    Chitale, D. A.; Broderick, S. R.; Ladanyi, M.
    Journal of Molecular Diagnostics (2007)

    Fulltext@MSK | Save
  • MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
    Meeting Abstract

    Bean, J.; Brennan, C.; Shih, J. Y.; Riely, G.; Viale, A.; Wang, L.; Chitale, D.; Motoi, N.; Szoke, J.; Broderick, S.; more...
    Molecular Cancer Therapeutics (2007)

    Fulltext@MSK | Save